GF
ACOR

Gabelli Funds’s Acorda Therapeutics ACOR Stock Holding History

Gabelli Funds’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-87
Closed -$7K – 1365
2020
Q4 		$7K Hold
87
– – ﹤0.01% 1211
2020
Q3 		$5K Sell
87
-83
-49% -$6.26K ﹤0.01% 1127
2020
Q2 		$15K Buy
170
+83
+95% +$8.77K ﹤0.01% 1056
2020
Q1 		$10K Hold
87
– – ﹤0.01% 1073
2019
Q4 		$21K Hold
87
– – ﹤0.01% 1093
2019
Q3 		$30K Hold
87
– – ﹤0.01% 1111
2019
Q2 		$80K Buy
+87
New +$107K ﹤0.01% 1117

Other funds holding ACOR

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gabelli Funds's ACOR Position: Q1 2021 in Review

Gabelli Funds sold out of Acorda Therapeutics (ACOR) in Q1 2021, closing a stake of 87 shares — an estimated $7K sold.

Gabelli Funds first reported a position in ACOR in Q2 2019 and held it in 7 quarters. The position peaked at $80K in Q2 2019. 32 funds tracked by Wall St. Rank hold ACOR as of Q1 2021.

  • Gabelli Funds reported no remaining Acorda Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Gabelli Funds sold 87 Acorda Therapeutics shares in Q1 2021, an estimated $7K.
  • Gabelli Funds first reported a position in Acorda Therapeutics in Q2 2019 and held it in 7 quarters.
  • Gabelli Funds's Acorda Therapeutics position peaked at $80K in Q2 2019.
  • 32 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2021.

Based on Gabelli Funds's 13F filing for Q1 2021, filed 14 May 2021.